Pfizer Indonesia is primarily engaged in pharmaceutical preparations activity. Its headquarters is located in Dki Jakarta. The company was founded in 1969. Pfizer Indonesia operates as a subsidiary of Pfizer Inc., a global pharmaceutical giant headquartered in New York, USA. The company was established to cater to the growing healthcare needs in Indonesia and has since become a significant player in the country's pharmaceutical industry. Pfizer Indonesia focuses on the development, production, and distribution of a wide range of pharmaceutical products, including vaccines, oncology treatments, and medications for cardiovascular, metabolic, and inflammatory diseases. Some of its well-known product brands include Lipitor, Viagra, and Prevnar. The company has a robust local presence with several branches and distribution centers across Indonesia, ensuring the availability of its products nationwide. Pfizer Indonesia also plays a crucial role in the global operations of Pfizer Inc., contributing to the company's research and development efforts and participating in clinical trials. Pfizer Indonesia collaborates with various healthcare organizations and government bodies to improve public health outcomes in the region. It is a member of several industry associations, including the Indonesian Pharmaceutical Association, and actively participates in initiatives to enhance healthcare access and quality. With a commitment to innovation and patient care, Pfizer Indonesia aims to advance wellness and healthcare in Indonesia. The company's mission aligns with Pfizer Inc.'s global vision of becoming the world's most valued company to patients, customers, colleagues, investors, business partners, and the communities where they work and live.
Headquarters
RT 014 RW 001
South Jakarta; Jakarta;
Postal Code: 12920
Contact Details: Purchase the PT Pfizer Indonesia report to view the information.
Website: http://www.pfizer.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service